Niagen Bioscience Inc’s recent filing unveils that its SVP, General Counsel Lopez Carlos Luis acquired Company’s shares for reported $2146.0 on Mar 07 ’25. In the deal valued at $7.86 per share,273 shares were bought. As a result of this transaction, Lopez Carlos Luis now holds 2,251 shares worth roughly $15464.37.
Then, Jaksch Frank L Jr sold 37,161 shares, generating $229,956 in total proceeds. Upon selling the shares at $6.19, the Director now owns 244,179 shares.
Before that, Frank Jaksch Jr. bought 37,161 shares. Niagen Bioscience Inc shares valued at $229,961 were divested by the affiliate at a price of $6.19 per share.
Oppenheimer downgraded its Niagen Bioscience Inc [NAGE] rating to a Perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who decreased its forecast for the stock in mid August from “a Buy” to “a Neutral”. ROTH Capital began covering NAGE with “Buy” recommendation on March 08, 2022. Oppenheimer started covering the stock on October 16, 2019. It rated NAGE as “an Outperform”.
Price Performance Review of NAGE
On Tuesday, Niagen Bioscience Inc [NASDAQ:NAGE] saw its stock fall -0.43% to $6.87. Over the last five days, the stock has lost -8.64%. Niagen Bioscience Inc shares have risen nearly 29.50% since the year began. Nevertheless, the stocks have risen 97.41% over the past one year. While a 52-week high of $9.18 was reached on 03/05/25, a 52-week low of $2.31 was recorded on 01/07/25. SMA at 50 days reached $6.47, while 200 days put it at $4.83.
Levels Of Support And Resistance For NAGE Stock
The 24-hour chart illustrates a support level at 6.68, which if violated will result in even more drops to 6.50. On the upside, there is a resistance level at 7.00. A further resistance level may holdings at 7.14. The Relative Strength Index (RSI) on the 14-day chart is 46.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.67, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.71%. Stochastics %K at 13.80% indicates the stock is a buying.
How much short interest is there in Niagen Bioscience Inc?
A steep rise in short interest was recorded in Niagen Bioscience Inc stocks on 2025-02-28, dropping by 7175.0 shares to a total of 2.11 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 2.11 million shares. There was a decline of -0.34%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 14, 2019 when B. Riley FBR began covering the stock and recommended ‘”a Buy”‘ rating along with a $7 price target.
